Psoriasis Biosimilars Market Outlook from 2024 to 2034: Breakthroughs in Treatment
The global psoriasis biosimilars market is poised for substantial growth, with sales estimated to rise from USD 9,228.6 million in 2024 to a staggering USD 26,679.9 million by 2034. This represents a robust compound annual growth rate (CAGR) of 11.2% over the forecast period. In 2023, the market generated a revenue of USD 8,412.6 million, reflecting a growing demand for affordable and...
0 Comments 0 Shares 2K Views 0 Reviews
Sponsored
Sponsored
Sponsored
google-site-verification: google037b30823fc02426.html